Rate My Professor Andrea Johns

Dr. Johns' research interests include DNA methylation, breast cancer, colorectal cancer, gene expression, microRNA, and tissue culture. She has co-authored numerous peer-reviewed publications demonstrating her contributions to cancer genomics and gastrointestinal research. Key publications include: Fortuno C et al., 'Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres', European Journal of Human Genetics (2024); Pariyar M et al., 'Copy number variation in triple negative breast cancer samples associated with lymph node metastasis', Neoplasia (2021); Burns GL et al., 'TRAV26-2 T-Cell Receptor Expression Is Associated With Mucosal Lymphocyte Response to Wheat Proteins in Patients With Functional Dyspepsia', Clinical and Translational Gastroenterology (2023); Burns GL et al., 'Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia', Frontiers in Immunology (2023); and Goggins BJ et al., 'Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function', American Journal of Physiology-Gastrointestinal and Liver Physiology (2021). Dr. Johns has held her postdoctoral researcher position in the Faculty of Health and Medicine, School of Biomedical Sciences and Pharmacy, since November 2016.